Search results (103)
« Back to PublicationsReal-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).
Journal article
Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12
Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.
Journal article
Schmid P. et al, (2026), Clin Cancer Res
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.
Journal article
Beernaert B. et al, (2026), Sci Adv, 12
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis.
Journal article
Kazmi F. et al, (2025), Clin Oncol (R Coll Radiol), 48
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.
Journal article
Cortés J. et al, (2025), Clin Cancer Res, 31, 4953 - 4963
Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Figure 6 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Data from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Other
Cheng VWT. et al, (2025)
Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.
Journal article
Pinho MP. et al, (2025), Cell Rep Med, 6
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer.
Journal article
Kazmi F. et al, (2025), Cochrane Database Syst Rev, 3
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Journal article
Coombes RC. et al, (2025), Nat Commun, 16